Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 17.77M | $ 15.33M | $ 26.27M | $ 23.04M | $ 20.05M |
Total Assets | $ 225.52M | $ 208.34M | $ 225.37M | $ 228.48M | $ 226.69M |
Total Debt | $ 65.60M | $ 56.62M | $ 75.58M | $ 77.66M | $ 78.12M |
Net Debt | $ 47.83M | $ 41.29M | $ 49.31M | $ 54.62M | $ 58.06M |
Total Liabilities | $ 106.18M | $ 89.45M | $ 108.24M | $ 111.91M | $ 113.37M |
Stockholders Equity | $ 119.34M | $ 118.89M | $ 117.13M | $ 116.57M | $ 113.33M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |